Search

Your search keyword '"Jing Shan"' showing total 3,656 results

Search Constraints

Start Over You searched for: Author "Jing Shan" Remove constraint Author: "Jing Shan"
3,656 results on '"Jing Shan"'

Search Results

201. Suppression of hnRNP A1 binding to HK1 RNA leads to glycolytic dysfunction in Alzheimer’s disease models

205. Design, kinematics, and prototyping of a gripping mechanism to adapt large space

213. 應用類神經網路進行台灣地區颱風系集降雨機率預報校正

215. Ethephon ripening affects boll weight and fiber quality of machine-harvested cotton.

216. Revolutionizing Solar Power Forecasts by Correcting the Outputs of the WRF-SOLAR Model.

223. Microphysical Perturbation Experiments and Ensemble Forecasts on Summertime Heavy Rainfall over Northern Taiwan

225. A software program for automated compressive vertebral fracture detection on elderly women’s lateral chest radiograph: Ofeye 1.0

232. Supplementary_table_S5 from Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin

233. Supplementary Figure S1-S17 from Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin

234. Data from Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin

242. Why high spatial resolution matters: narrow fault zone, but big effects observed by Taiwan Milun-fault Drilling and All-inclusive Sensing (Taiwan MiDAS) project

243. Influencing factors of COVID-19 vaccination hesitancy among adults in Taiwan, China: a cross-sectional study

245. Supplementary_table_S1 from Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin

246. Data from ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models

247. Supplementary Figure 1 from ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models

248. Supplementary Figure S1 - S8 from Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody–Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast Cancers

249. Supplementary Figure S1-S17 from Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin

250. Supplementary Methods from Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody–Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast Cancers

Catalog

Books, media, physical & digital resources